Carmila: Withdrawal of funds for the liquidity contract
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom forecasts quarterly sales below estimates amid rising custom AI chip competition
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
Carisma Therapeutics Inc (CARM) PT Lowered to $4 at Evercore ISI
May 10, 2024 6:21 AM EDTEvercore ISI analyst Liisa Bayko lowered the price target on Carisma Therapeutics Inc (NASDAQ: CARM) to $4.00 (from $12.00) while maintaining a Outperform rating.
The analyst comments "CARM is trading just above $57M of cash, which is probably runway into 3Q25 and past the next... More
